Aprea Therapeutics
APRE
#10389
Rank
NZ$11.5 M
Marketcap
NZ$1.64
Share price
0.54%
Change (1 day)
-73.24%
Change (1 year)

Earnings for Aprea Therapeutics (APRE)

Earnings in 2025 (TTM): -NZ$23.87 Million

According to Aprea Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$24.92 Million, an increase over its 2023 earnings that were of -NZ$26.93 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aprea Therapeutics from 2019 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$23.87 Million-4.23%
2024 -NZ$24.92 Million-7.45%
2023 -NZ$26.93 Million-58.6%
2022 -NZ$65.04 Million-0.2%
2021 -NZ$65.17 Million-29.09%
2020 -NZ$91.91 Million64.34%
2019 -NZ$55.93 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Magellan Health
MGLN
NZ$37.28 M-255.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Healthcare Services Group
HCSG
NZ$98.32 M-508.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Amedisys
AMED
NZ$0.25 B-1,180.50%๐Ÿ‡บ๐Ÿ‡ธ USA